Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|41|6234-6250

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.41, 2016-12, pp. : 6234-6250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Era of Immunotherapy in Prostate Cancer

By  

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-09 ,pp. : 217-225

Bentham Science Publishers

Access to resources Recommend Favorite

Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3804-3811

Bentham Science Publishers

Access to resources Recommend Favorite

WT1 as a Novel Target Antigen for Cancer Immunotherapy

By  

Current Cancer Drug Targets, Vol. 2, Iss. 1, 2002-03 ,pp. : 45-54

Bentham Science Publishers

Access to resources Recommend Favorite

The cancer stem cell paradigm: a new understanding of tumor development and treatment

By Ebben Johnathan D   Treisman Daniel M   Zorniak Michael   Kutty Raman G   Clark Paul A   Kuo John S  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 621-632

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 223-237

Bentham Science Publishers

Access to resources Recommend Favorite